| __timestamp | Amgen Inc. | Dynavax Technologies Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 4297000000 | 84580000 |
| Thursday, January 1, 2015 | 4070000000 | 86943000 |
| Friday, January 1, 2016 | 3840000000 | 84493000 |
| Sunday, January 1, 2017 | 3562000000 | 64988000 |
| Monday, January 1, 2018 | 3737000000 | 74951000 |
| Tuesday, January 1, 2019 | 4116000000 | 62331000 |
| Wednesday, January 1, 2020 | 4207000000 | 28607000 |
| Friday, January 1, 2021 | 4819000000 | 32228000 |
| Saturday, January 1, 2022 | 4434000000 | 46600000 |
| Sunday, January 1, 2023 | 4784000000 | 54886000 |
| Monday, January 1, 2024 | 5964000000 |
Unleashing the power of data
In the ever-evolving landscape of biotechnology, research and development (R&D) budgets are a testament to a company's commitment to innovation. Over the past decade, Amgen Inc. has consistently outpaced Dynavax Technologies Corporation in R&D spending. From 2014 to 2023, Amgen's R&D expenses have shown a steady increase, peaking in 2021 with a 35% rise from its 2017 low. In contrast, Dynavax's R&D budget has fluctuated, with a notable dip in 2020, reflecting a 66% decrease from its 2015 peak. This disparity highlights Amgen's robust investment strategy, which is nearly 70 times larger than Dynavax's average annual R&D expenditure. As the biotech industry continues to grow, these financial commitments underscore the strategic priorities of each company, with Amgen focusing on sustained innovation and Dynavax navigating a more variable investment path.
Comparing Innovation Spending: Novo Nordisk A/S and Dynavax Technologies Corporation
Analyzing R&D Budgets: Novartis AG vs Dynavax Technologies Corporation
R&D Spending Showdown: Amgen Inc. vs Lantheus Holdings, Inc.
Comparing Innovation Spending: Amgen Inc. and Rhythm Pharmaceuticals, Inc.
Analyzing R&D Budgets: Amgen Inc. vs Catalyst Pharmaceuticals, Inc.
Analyzing R&D Budgets: Amgen Inc. vs HUTCHMED (China) Limited
Who Prioritizes Innovation? R&D Spending Compared for Amgen Inc. and Iovance Biotherapeutics, Inc.
R&D Spending Showdown: Amgen Inc. vs Taro Pharmaceutical Industries Ltd.
Analyzing R&D Budgets: Zoetis Inc. vs Dynavax Technologies Corporation
Neurocrine Biosciences, Inc. vs Dynavax Technologies Corporation: Strategic Focus on R&D Spending
Comparing Innovation Spending: Ionis Pharmaceuticals, Inc. and Dynavax Technologies Corporation
Catalyst Pharmaceuticals, Inc. or Dynavax Technologies Corporation: Who Invests More in Innovation?